Is it time to change diabetic disease nomenclature? Abduelmula R. AbduelkaremMike A. SackvilleAnthony J. Hildreth Commentary Pages: 3 - 5
Massive nasal bleeding and hemodynamic instability associated with clopidogrel Flávio E. NáculEmanuela de MoraesJoão G.C. Méier-Neto OriginalPaper Pages: 6 - 7
Clostridium difficile colitis associated with valaciclovir Susana De AndrésDaniel FerreiroJose Luis Agud OriginalPaper Pages: 8 - 9
Medication error due to ambiguous labelling of a commercial product Henk-Jan GuchelaarMathijs D. KalmeijerMinke E.P. Jansen OriginalPaper Pages: 10 - 11
The nature of informal pain questioning by nurses – a barrier to post-operative pain management? Ellen I. SchafheutleJudith A. CantrillPeter R. Noyce OriginalPaper Pages: 12 - 17
Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team – a pilot study Joel WermeilleMarion BennieJohn McKnight OriginalPaper Pages: 18 - 25
Unclaimed prescriptions after automated prescription transmittals to pharmacies Anders EkedahlNiclas Månsson OriginalPaper Pages: 26 - 31
Simulated patients in the community pharmacy setting – Using simulated patients to measure practice in the community pharmacy setting Margaret C. WatsonJohn R. SkeltonJill Mollison OriginalPaper Pages: 32 - 37
Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation Nuria CorominasJosep RibasGines Sanz OriginalPaper Pages: 38 - 43
The effectiveness of hospital pharmacy in the UK: methodology for finding the evidence Damian ChildJudith CantrillJonathan Cooke OriginalPaper Pages: 44 - 51
Dispensing glucose test materials in Dutch community pharmacies Michiel J. StorimansHerre TalsmaCornelis J. de Blaey OriginalPaper Pages: 52 - 55